Home Insurance IBA and SOGAZ Insurance coverage Group signal contract for Proteus®ONE

IBA and SOGAZ Insurance coverage Group signal contract for Proteus®ONE

0
IBA and SOGAZ Insurance coverage Group signal contract for Proteus®ONE

[ad_1]

Louvain-La-Neuve, Belgium, February 14, 2022 – IBA (Ion Beam Purposes S.A., EURONEXT), the world chief in particle accelerator know-how and the world’s main supplier of proton remedy options for the therapy of most cancers, immediately pronounces a brand new contract with SOGAZ Insurance coverage Group (“SOGAZ Group”) for the set up of a Proteus®ONE1 proton remedy resolution in Saint Petersburg, Russia. The contract features a multi-year operation and upkeep settlement to be supplied by IBA. SOGAZ Group expects to start out treating sufferers in 2024.

The system is the primary Proteus®ONE resolution to be put in in Russia, positioned on the SOGAZ Excessive-tech Multidisciplinary Medical Advanced, in Jukki, simply outdoors of Saint Petersburg. Will probably be geared up with newest era Open Gantry, Pencil Beam Scanning (PBS), Cone Beam Computed Tomography (CBCT), wi-fi hand pendant and a completely built-in high quality assurance (QA) {hardware} and software program bundle from IBA Dosimetry GmbH. Notably, the Proteus®ONE system beforehand demonstrated its potential to ship Flash Extremely Excessive Dose Charges at Isocenter in a scientific setting2 The Proteus®ONE is the newest era cyclotron-based compact proton remedy system with market clearance within the Russian Federation immediately.

The standard end-user value for a Proteus®ONE system with a multi-year upkeep contract ranges between 35-45 million EUR. IBA has obtained the primary cost and can begin recognizing this income in 2022. That is the 31st Proteus®ONE system offered worldwide, of which, 12 are presently clinically operational.

Olivier Legrain, Chief Govt Officer of IBA, commented: “This newest contract additional demonstrates the rising momentum of proton remedy worldwide, while reinforcing IBA’s main place within the Russian market. We look ahead to partnering with SOGAZ and are happy to welcome them to IBA Campus3, the biggest group of proton remedy specialists.”

Anton Ustinov, Chairman of the Administration Board of SOGAZ Group, added, “SOGAZ Group seeks to offer the newest and most superior medical know-how to our most cancers sufferers in want of the absolute best care. Including proton remedy to our clinic will present extra therapy choices for our world-class clinicians. We’re glad to companion with IBA which continues to be the chief in proton remedy innovation.

***Ends***

About IBA

IBA (Ion Beam Purposes S.A.) is the world chief in particle accelerator know-how. The corporate is the main provider of apparatus and providers within the subject of proton remedy, thought-about to be essentially the most superior type of radiation remedy accessible immediately. IBA can also be a number one participant within the fields of commercial sterilization, radiopharmaceuticals and dosimetry. The corporate, based mostly in Louvain-la-Neuve, Belgium, employs roughly 1,500 folks worldwide. IBA is an authorized B Company (B Corp) assembly the best requirements of verified social and environmental efficiency.

IBA is listed on the pan-European inventory trade EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

Extra data might be discovered at: www.iba-worldwide.com

About Sogaz Insurance coverage Group
SOGAZ Insurance coverage Group was based in 1993 and is the biggest federal degree insurer in Russia. The group provides greater than 100 insurance coverage applications for people and enterprises in numerous fields of exercise. Reliability and monetary stability of the Group corporations are proved by main worldwide and Russian ranking businesses. The regional community of the Group contains greater than 1,000 divisions and gross sales workplaces all through Russia.

CONTACTS

Soumya Chandramouli
Chief Monetary Officer
+32 10 475 890
Investorrelations@iba-group.com

Olivier Lechien
Company Communication Director
+32 10 475 890
communication@iba-group.com

Consilium Strategic Communications
Amber Fennell, Angela Grey, Lucy Featherstone
+44 (0) 20 3709 5700
IBA@consilium-comms.com


1 Proteus®ONE is a model title of Proteus 235

2https://www.iba-worldwide.com/content material/flash-irradiation-delivered-proteus-one-treatment-room

3 Join on Campus-iba.com to hitch the biggest group of proton remedy specialists .

[ad_2]

Supply hyperlink

LEAVE A REPLY

Please enter your comment!
Please enter your name here